Under the “One Big Beautiful Bill Act," 10.9 million Americans would lose health insurance by 2034, according to estimates by ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

The FDA has removed the REMS program requirement for currently approved BCMA- and CD19-directed autologous CAR T-cell therapies.

These findings suggest a need to investigate whether age-specific trends are due to guidelines that suggest reduced screening for older age groups,” the researchers wrote.

The ACIP has recommended that patients only receive seasonal influenza vaccines that do not contain thimerosal.

Adding ibrutinib to rituximab improved outcomes in patients with previously untreated FL who were ineligible for CIT.